170 related articles for article (PubMed ID: 35025764)
1. ATP11B inhibits breast cancer metastasis in a mouse model by suppressing externalization of nonapoptotic phosphatidylserine.
Xu J; Su SM; Zhang X; Chan UI; Adhav R; Shu X; Liu J; Li J; Mo L; Wang Y; An T; Lei JH; Miao K; Deng CX; Xu X
J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35025764
[TBL] [Abstract][Full Text] [Related]
2. Visualization and quantification of
Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
[TBL] [Abstract][Full Text] [Related]
3. CXCL17-derived CD11b
Hsu YL; Yen MC; Chang WA; Tsai PH; Pan YC; Liao SH; Kuo PL
Breast Cancer Res; 2019 Feb; 21(1):23. PubMed ID: 30755260
[TBL] [Abstract][Full Text] [Related]
4. Blocking antibody-mediated phosphatidylserine enhances cancer immunotherapy.
Zhang J; Dai Z; Yan C; Wang D; Tang D
J Cancer Res Clin Oncol; 2021 Dec; 147(12):3639-3651. PubMed ID: 34499223
[TBL] [Abstract][Full Text] [Related]
5. Aiduqing formula inhibits breast cancer metastasis by suppressing TAM/CXCL1-induced Treg differentiation and infiltration.
Li J; Wang S; Wang N; Zheng Y; Yang B; Wang X; Zhang J; Pan B; Wang Z
Cell Commun Signal; 2021 Aug; 19(1):89. PubMed ID: 34461944
[TBL] [Abstract][Full Text] [Related]
6. Knockout of MDA-9/Syntenin (SDCBP) expression in the microenvironment dampens tumor-supporting inflammation and inhibits melanoma metastasis.
Das SK; Guo C; Pradhan AK; Bhoopathi P; Talukdar S; Shen XN; Emdad L; Subler MA; Windle JJ; Sarkar D; Wang XY; Fisher PB
Oncotarget; 2016 Jul; 7(30):46848-46861. PubMed ID: 27341128
[TBL] [Abstract][Full Text] [Related]
7. A phase I clinical trial of bavituximab and paclitaxel in patients with HER2 negative metastatic breast cancer.
Chalasani P; Marron M; Roe D; Clarke K; Iannone M; Livingston RB; Shan JS; Stopeck AT
Cancer Med; 2015 Jul; 4(7):1051-9. PubMed ID: 25826750
[TBL] [Abstract][Full Text] [Related]
8. [Roles of Myeloid-derived Suppressor Cells in Breast Cancer Metastasis].
Peng XY; Li Y; Xu ZL; Guo Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):445-451. PubMed ID: 34238422
[TBL] [Abstract][Full Text] [Related]
9. Targeting phosphatidylserine for Cancer therapy: prospects and challenges.
Chang W; Fa H; Xiao D; Wang J
Theranostics; 2020; 10(20):9214-9229. PubMed ID: 32802188
[TBL] [Abstract][Full Text] [Related]
10. Periostin promotes immunosuppressive premetastatic niche formation to facilitate breast tumour metastasis.
Wang Z; Xiong S; Mao Y; Chen M; Ma X; Zhou X; Ma Z; Liu F; Huang Z; Luo Q; Ouyang G
J Pathol; 2016 Aug; 239(4):484-95. PubMed ID: 27193093
[TBL] [Abstract][Full Text] [Related]
11. Neutralization of TNFα in tumor with a novel nanobody potentiates paclitaxel-therapy and inhibits metastasis in breast cancer.
Ji X; Peng Z; Li X; Yan Z; Yang Y; Qiao Z; Liu Y
Cancer Lett; 2017 Feb; 386():24-34. PubMed ID: 27832973
[TBL] [Abstract][Full Text] [Related]
12. A mutual activation loop between breast cancer cells and myeloid-derived suppressor cells facilitates spontaneous metastasis through IL-6 trans-signaling in a murine model.
Oh K; Lee OY; Shon SY; Nam O; Ryu PM; Seo MW; Lee DS
Breast Cancer Res; 2013; 15(5):R79. PubMed ID: 24021059
[TBL] [Abstract][Full Text] [Related]
13. Circulating myeloid-derived suppressor cells: An independent prognostic factor in patients with breast cancer.
Safarzadeh E; Hashemzadeh S; Duijf PHG; Mansoori B; Khaze V; Mohammadi A; Kazemi T; Yousefi M; Asadi M; Mohammadi H; Babaie F; Baradaran B
J Cell Physiol; 2019 Apr; 234(4):3515-3525. PubMed ID: 30362521
[TBL] [Abstract][Full Text] [Related]
14. PMN-MDSCs Enhance CTC Metastatic Properties through Reciprocal Interactions via ROS/Notch/Nodal Signaling.
Sprouse ML; Welte T; Boral D; Liu HN; Yin W; Vishnoi M; Goswami-Sewell D; Li L; Pei G; Jia P; Glitza-Oliva IC; Marchetti D
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31003475
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of sulforaphane and doxorubicin attenuates breast cancer growth by preventing the accumulation of myeloid-derived suppressor cells.
Rong Y; Huang L; Yi K; Chen H; Liu S; Zhang W; Yuan C; Song X; Wang F
Cancer Lett; 2020 Nov; 493():189-196. PubMed ID: 32891712
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin prevents breast cancer metastasis through blocking early EMT and retards cancer growth together with paclitaxel.
Wang H; Guo S; Kim SJ; Shao F; Ho JWK; Wong KU; Miao Z; Hao D; Zhao M; Xu J; Zeng J; Wong KH; Di L; Wong AH; Xu X; Deng CX
Theranostics; 2021; 11(5):2442-2459. PubMed ID: 33500735
[TBL] [Abstract][Full Text] [Related]
17. The anthelmintic flubendazole blocks human melanoma growth and metastasis and suppresses programmed cell death protein-1 and myeloid-derived suppressor cell accumulation.
Li Y; Acharya G; Elahy M; Xin H; Khachigian LM
Cancer Lett; 2019 Sep; 459():268-276. PubMed ID: 31128215
[TBL] [Abstract][Full Text] [Related]
18. Phenformin Inhibits Myeloid-Derived Suppressor Cells and Enhances the Anti-Tumor Activity of PD-1 Blockade in Melanoma.
Kim SH; Li M; Trousil S; Zhang Y; Pasca di Magliano M; Swanson KD; Zheng B
J Invest Dermatol; 2017 Aug; 137(8):1740-1748. PubMed ID: 28433543
[TBL] [Abstract][Full Text] [Related]
19. Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice.
Wei L; Zhang X; Wang J; Ye Q; Zheng X; Peng Q; Zheng Y; Liu P; Zhang X; Li Z; Liu C; Yan Q; Li G; Ma J
Oncogene; 2020 Jan; 39(1):122-135. PubMed ID: 31462711
[TBL] [Abstract][Full Text] [Related]
20. Anti-PD1 antibody enhances the anti-tumor efficacy of MUC1-MBP fusion protein vaccine via increasing Th1, Tc1 activity and decreasing the proportion of MDSC in the B16-MUC1 melanoma mouse model.
Zhang Z; Zhou H; Liu Y; Ren J; Wang J; Sang Q; Lan Y; Wu Y; Yuan H; Ni W; Tai G
Int Immunopharmacol; 2021 Dec; 101(Pt A):108173. PubMed ID: 34607233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
